TenSixty BioSciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

TenSixty BioSciences General Information

Description

Developer of epitope-defined oncology therapeutics designed to identify tumor-selective targets and develop antibody-based treatments for cancer. The company uses native tumor biology, proteoform-level analysis, computational modeling, single-cell profiling, and antibody discovery to identify tumor-selective epitopes and generate therapeutic binders for antibody-drug conjugates, enabling clinicians to access T-cell engagers and multispecifics to advance a pipeline of investigational treatments for solid tumors and other cancer indications.

Contact Information

Website
www.tensixty.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TenSixty BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jan-2023 Completed Startup
2. Accelerator/Incubator 01-Sep-2022 Completed Startup
1. Seed Round 24-Aug-2022 $7.2M $7.2M Completed Startup
To view TenSixty BioSciences’s complete valuation and funding history, request access »

TenSixty BioSciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view TenSixty BioSciences’s complete cap table history, request access »

TenSixty BioSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of epitope-defined oncology therapeutics designed to identify tumor-selective targets and develop antibody-bas
Biotechnology
Cambridge, MA
5 As of 2026

South San Francisco, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TenSixty BioSciences Competitors (32)

One of TenSixty BioSciences’s 32 competitors is Cartography Biosciences, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cartography Biosciences Venture Capital-Backed South San Francisco, CA
Tegmine Therapeutics Venture Capital-Backed San Francisco, CA
Arda Therapeutics Venture Capital-Backed San Carlos, CA
CD Genomics Corporation Shirley, NY
GeneCast Biotechnology Private Equity-Backed Wuxi, China
You’re viewing 5 of 32 competitors. Get the full list »

TenSixty BioSciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TenSixty BioSciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Engine Accelerator/Incubator
Civilization Ventures Venture Capital Minority
General Catalyst Venture Capital Minority
HBM Genomics Venture Capital Minority
Wing Venture Capital Venture Capital Minority
To view TenSixty BioSciences’s complete investors history, request access »

Ready to get started?

Request a free trial

TenSixty BioSciences FAQs

  • When was TenSixty BioSciences founded?

    TenSixty BioSciences was founded in 2021.

  • Where is TenSixty BioSciences headquartered?

    TenSixty BioSciences is headquartered in Cambridge, MA.

  • What is the size of TenSixty BioSciences?

    TenSixty BioSciences has 5 total employees.

  • What industry is TenSixty BioSciences in?

    TenSixty BioSciences’s primary industry is Biotechnology.

  • Is TenSixty BioSciences a private or public company?

    TenSixty BioSciences is a Private company.

  • What is TenSixty BioSciences’s current revenue?

    The current revenue for TenSixty BioSciences is .

  • How much funding has TenSixty BioSciences raised over time?

    TenSixty BioSciences has raised $7.2M.

  • Who are TenSixty BioSciences’s investors?

    The Engine, Civilization Ventures, General Catalyst, HBM Genomics, and Wing Venture Capital have invested in TenSixty BioSciences.

  • Who are TenSixty BioSciences’s competitors?

    Cartography Biosciences, Tegmine Therapeutics, Arda Therapeutics, CD Genomics, and GeneCast Biotechnology are some of the 32 competitors of TenSixty BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process